Evidence map›Paper›PMID 33378381›Full record

ArticlePloS one2020

metaVaR: Introducing metavariant species models for reference-free metagenomic-based population genomics.

Romuald Laso-Jadart, Christophe Ambroise, Pierre Peterlongo, Mohammed-Amin Madoui

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Romuald Laso-JadartInstitut François Jacob, CEA, CNRS, Génomique Métabolique - UMR 8030, Univ Evry, Université Paris-Saclay, Evry, France.
Christophe AmbroiseIBGBI-LaMME, Univ Evry, Université Paris-Saclay, Evry, France.
Pierre PeterlongoInria, CNRS, IRISA, Univ Rennes, Rennes, France.
Mohammed-Amin MadouiInstitut François Jacob, CEA, CNRS, Génomique Métabolique - UMR 8030, Univ Evry, Université Paris-Saclay, Evry, France.ORCID 0000-0003-4809-2971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The availability of large metagenomic data offers great opportunities for the population genomic analysis of uncultured organisms, which represent a large part of the unexplored biosphere and play a key ecological role. However, the majority of these organisms lack a reference genome or transcriptome, which constitutes a technical obstacle for classical population genomic analyses. We introduce the metavariant species (MVS) model, in which a species is represented only by intra-species nucleotide polymorphism. We designed a method combining reference-free variant calling, multiple density-based clustering and maximum-weighted independent set algorithms to cluster intra-species variants into MVSs directly from multisample metagenomic raw reads without a reference genome or read assembly. The frequencies of the MVS variants are then used to compute population genomic statistics such as FST, in order to estimate genomic differentiation between populations and to identify loci under natural selection. The MVS construction was tested on simulated and real metagenomic data. MVSs showed the required quality for robust population genomics and allowed an accurate estimation of genomic differentiation (ΔFST < 0.0001 and <0.03 on simulated and real data respectively). Loci predicted under natural selection on real data were all detected by MVSs. MVSs represent a new paradigm that may simplify and enhance holistic approaches for population genomics and the evolution of microorganisms.

Indexed as

Genetic VariationCluster AnalysisComputational BiologyGenetics, PopulationMetagenomicsModels, GeneticSelection, GeneticSoftware

Identifiers

PMID33378381
PMCPMC7773188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.